Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Immune Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT04833465
What this trial is testing

Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions

Who this might be right for
Juvenile Idiopathic ArthritisSystemic Lupus ErythematosusFibromyalgia
Children's National Research Institute 90
Testing effectiveness (Phase 2)Looking for participantsNCT07247734
What this trial is testing

The Effect of Colchicine, on Insulin Sensitivity in Individuals With Type 1 Diabetes and Systemic Low-grade Inflammation

Who this might be right for
Type 1 DiabetesChronic InflammationInsulin Sensitivity
Asger Lund, MD 26
Testing effectiveness (Phase 2)Ended earlyNCT05540665
What this trial is testing

Study of Daxdilimab (HZN-7734) in Participants With Active Proliferative Lupus Nephritis (LN)

Who this might be right for
Lupus Nephritis
Amgen 19
Post-approval studies (Phase 4)UnknownNCT02270970
What this trial is testing

Evaluation of Belimumab Impact on a BLyS Activity Signature Test in the Absence of Confounding Polypharmacy

Who this might be right for
Systemic Lupus Erythematosus
Oklahoma Medical Research Foundation 20
Testing effectiveness (Phase 2)Study completedNCT00003353
What this trial is testing

High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Eastern Cooperative Oncology Group
Large-scale testing (Phase 3)Ended earlyNCT03517722
What this trial is testing

Ustekinumab in Participants With Active Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
Janssen Research & Development, LLC 516
Not applicableLooking for participantsNCT00001372
What this trial is testing

Study of Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 2,000
Testing effectiveness (Phase 2)WithdrawnNCT01101412
What this trial is testing

Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies

Who this might be right for
Chronic Myeloproliferative DisordersInfectionLeukemia+6 more
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01162681
What this trial is testing

PEARL-SC Trial: A Study of the Efficacy, Safety, and Tolerability of A 623 Administration in Subjects With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Anthera Pharmaceuticals 547
Testing effectiveness (Phase 2)Looking for participantsNCT07053800
What this trial is testing

Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)

Who this might be right for
Lupus Nephritis
Autolus Limited 35
Not applicableStudy completedNCT01413230
What this trial is testing

Vitamin D Supplementation in Systemic Lupus Erythematosus

Who this might be right for
Vitamin D Deficiency
Assistance Publique - Hôpitaux de Paris 20
Early research (Phase 1)Looking for participantsNCT06826430
What this trial is testing

Inaticabtagene Autoleucel Injection in the Treatment of Refractory Systemic Lupus Erythematosus-related Immune Thrombocytopenia

Who this might be right for
Autoimmune Thrombocytopenia
Juventas Cell Therapy Ltd. 12
Post-approval studies (Phase 4)UnknownNCT04893161
What this trial is testing

A Model About the Response of Belimumab in SLE

Who this might be right for
Systemic Lupus Erythematosus
First Affiliated Hospital Xi'an Jiaotong University 72
Not applicableStudy completedNCT05329831
What this trial is testing

Effects of Telehealth Initiative on Lupus Patients

Who this might be right for
Systemic Lupus Erythematosus
Selcuk University 110
Testing effectiveness (Phase 2)UnknownNCT04835883
What this trial is testing

Exploring the Efficacy and Safety of CS20AT04 (Allogenic Bone Marrow-Derived Stem Cell) in Systemic Lupus Erythematosus Patients

Who this might be right for
Systemic Lupus Erythematosus
Hanyang University Seoul Hospital 10
Large-scale testing (Phase 3)Ended earlyNCT00886769
What this trial is testing

Single-dose Study to Assess Efficacy of Canakinumab (ACZ885) in Patients With Active Juvenile Idiopathic Arthritis (SJIA)

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Novartis Pharmaceuticals 84
Testing effectiveness (Phase 2)Study completedNCT04761822
What this trial is testing

COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations

Who this might be right for
SARS-CoV InfectionCOVID-19Allergic Reaction+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 746
Not applicableUnknownNCT06361745
What this trial is testing

Early Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusIdiopathic Inflammatory MyopathiesSystemic Sclerosis+2 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Testing effectiveness (Phase 2)Study completedNCT01072773
What this trial is testing

Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Light Chain Amyloidosis

Who this might be right for
Primary Systemic Amyloidosis
Mayo Clinic 2
Early research (Phase 1)Study completedNCT05702983
What this trial is testing

The Safety and Tolerability of STSA-1002 Following Subcutaneous Injection in Healthy Subjects

Who this might be right for
Antineutrophil Cytoplasmic Antibody Associated Vasculitis
Staidson (Beijing) Biopharmaceuticals Co., Ltd 20
Next Page